Newswise — BETHESDA, Md. – July 13, 2017 – The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced the results of its 2017 Leadership Elections. AMP is an organization driven by the dedication of its volunteers and looks forward to working with these newly elected leaders.
| President-Elect | Victoria M. Pratt, PhD Indiana University School of Medicine | |
| Secretary-Treasurer | Daniel E. Sabath, MD, PhD
| |
| Program Committee Chair-Elect | Neil I. Lindeman, MD Brigham & Women's Hospital, Harvard School of Medicine | |
| Publication and Communication Committee Chair | Paul G. Rothberg, PhD University of Rochester Medicine, Strong Memorial Hospital | |
| Training and Education Committee Chair | Cecilia Yeung, MD Fred Hutchinson Cancer Research Center, University of Washington, Seattle Cancer Care Alliance | |
| Technical Topics Representative to the Program Committee | Fernanda Sabato, MS Virginia Commonwealth Univ/MCV Clinical Support Center | |
| Genetics Clinical Practice Committee Representative | Josh Deignan, PhD UCLA, David Geffen School of Medicine | |
| Genetics Nominating Committee Representative | Bert Gold, PhD Natera, Inc. | |
| Genetics Program Committee Representative | Elaine B. Spector, PhD University of Colorado School of Medicine | |
| Genetics Training and Education Committee Representative | Yassmine M. N. Akkari, PhD Legacy Health | |
| Hematopathology Subdivision Chair | Annette S. Kim, MD, PhD Harvard Medical School, Brigham and Women's Hospital | |
| Hematopathology Clinical Practice Committee Representative | Noah Brown, MD University of Michigan, Ann Arbor, MI | |
| Hematopathology Nominating Committee Representative | David S. Viswanatha, MD Mayo Clinic | |
| Hematopathology Program Committee Representative | Y. Lynn Wang, MD, PhD University of Chicago | |
| Hematopathology Training and Education Committee Representative | Rashmi S. Goswami, MD, PhD University of Toronto | |
| Infectious Diseases Clinical Practice Committee Representative | Kenneth L. Muldrew, MD, MPH Baylor College of Medicine, University of North Texas MD Anderson Cancer Center, Baylor St. Luke's Hospital, Ben Taub Hospital, Harris Health System | |
| Infectious Diseases Nominating Committee Representative | Amanda T. Harrington, PhD Loyola University Medical Center | |
| Infectious Diseases Program Committee Representative | Jennifer Dien Bard, PhD Children’s Hospital Los Angeles; University of Southern California | |
| Infectious Diseases Training and Education Committee Representative | Preeti Pancholi, PhD The Ohio State University Wexner Medical Center | |
| Informatics Clinical Practice Committee Representative | Justin M. Zook, PhD National Institute of Standards and Technology | |
| Informatics Training and Education Committee Representative | Carlos Jose Suarez, MD Stanford University | |
| Informatics Program Committee Representative | Matthew Lebo, PhD Brigham and Women's Hospital, Harvard Medical School | |
| Informatics Training and Education Committee Representative | Joshua Coleman, MD GenomOncology, LLC | |
| Solid Tumors Subdivision Chair | Roger D. Klein, MD, JD Consultant, Roger D. Klein, MD, JD | |
| Solid Tumors Clinical Practice Committee Representative | Pranil K. Chandra, DO PathGroup | |
| Solid Tumors Nominating Committee Representative | Shelby D. Melton, MD, MS VA North Texas Health Care System | |
| Solid Tumors Program Committee Representative | Christina M. Lockwood, PhD University of Washington | |
| Solid Tumors Training and Education Committee Representative | Susan J. Hsiao, MD, PhD Columbia University Medical Center |
ABOUT AMP
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ members practice in the various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions and oncology. They include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing. For more information, visit www.amp.org. Follow AMP on Twitter: @AMPath.
RSS